{"name":"AtheroGenics","slug":"atherogenics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AGI-1067","genericName":"AGI-1067","slug":"agi-1067","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"AGI-1067","genericName":"AGI-1067","slug":"agi-1067","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPQmVwRkFJNXp3OENab2lEdTA4VDJtQW5fazBzVXAwV2cxSjNlbU9PNDAzVEQwd0pUclcxekdEZExKZ2NEM2JjcGZydmF0OTVVQnpOdXpMSDFtMi1LVDZJQS1WbHNuWnRNaVJQU19hRDJrbFh0ZE1IcWF5WkpSUkNrdy1ITndGLUh0S2NEaXJKQl9WNU00M2tMcGNaNHdPUENuelR1alhsZ3RQeDlvSW5Wd0J4djlTeUtJTkw4SXZCZG16bllLdFl5bnpzOUk?oc=5","date":"2026-03-03","type":"pipeline","source":"Dove Medical Press","summary":"TCRM - Dove Medical Press","headline":"TCRM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPakdpUTBxeDNPSFFRMkNiSlV5ZlZlYmh1US1pRVNUWi1pQllFZjBPaWNNRHZuQVlnc3JJeUQ3X3dzWm1OQmhNbG5PVUwtQ0tTdXBoOTVrbVhrMDU4Nng1bTBxNnMyX21BZWhYWWZaekVnUWcydWR6QU1EcmtxYk5pR0k3QWNKeGRTZHdMLXQ4NF9hM1E2NHBiZkhsQkE2bFVhOHYzVUE4MmZKaHhfeEhWTnlGMXE5UmlGQXFFR05fWm9vb010czE0?oc=5","date":"2024-05-28","type":"trial","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals Presents New Phase 2 Data of Plozasiran in Patients with Mixed Hyperlipidemia - Arrowhead Phar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOYTMyWldvN2xaZlM4dHV2UEU0c0RtX0JmbVNncGkxN3VjVGEzWnItUWEydkw4cnhGUFh4TWF6V3c2Q044SzBGdjUwRnpQSEwzUFJnZXpueWpyUDN0bHFHY2NFRnVPb2hqSXB5QThTemxuNWxpRHQ1OEEyV1EtTWgwNTIwQmJyenQ2em9VdnFWNHZ0YjRhUTFYcjlFRy1CaHB5WWJYLWRmV1pSOW9kVDBobU85WUxqdGVIN1JqaGEyTVM4ZFk?oc=5","date":"2024-05-01","type":"pipeline","source":"Healio","summary":"Obicetrapib, alone or with ezetimibe, reduces atherogenic lipoprotein particles - Healio","headline":"Obicetrapib, alone or with ezetimibe, reduces atherogenic lipoprotein particles","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-05-21","type":"pipeline","source":"The Hans India","summary":"This ex-pharma executive quits C-suite job to launch 3D bioprinting startup, aims to revolutionise drug... - The Hans India","headline":"This ex-pharma executive quits C-suite job to launch 3D bioprinting startup, aims to revolutionise drug...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1GOVAtcldlbVJPQTdTdWpWNFZPVkg4b1BqU3g3c2hNelVKR1dfRURoYWdKWS1tX2VCaXd2OUZ5TG9ldVRhdUlVdmJtSVh3Rm5fdUxjVTVKRHFtWWpvQVVWYkJsUmVGQTd2MEVJUFZadjU0S0c0SElR?oc=5","date":"2007-02-01","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"GEN’s Annual Wall Street Roundup - Genetic Engineering and Biotechnology News","headline":"GEN’s Annual Wall Street Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9qV3ZOMkpaN1g1aFVMOHFXSklKTEE1SVdVa3U4S1o1WnNDcjhYbDIxV2tsSEhuSTI5SlhrQ3Jpb2RFdXZzcjlMWlBoOXRMWnl3Q2FNODZoRjJmQzFsLU1MV19ZQWhlM2hiV1l1cHVYbFJ1eEhNMzRIQTV3?oc=5","date":"2006-01-09","type":"pipeline","source":"The Pharma Letter","summary":"AstraZeneca bids $210M for KuDOS Pharma - Pharmaceutical industry news - The Pharma Letter","headline":"AstraZeneca bids $210M for KuDOS Pharma - Pharmaceutical industry news","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}